Nanoencapsulation of omega-3 and curcumin for alzheimer's-related vision preservation
A novel approach using nanoencapsulation of DHA and curcumin with lysophospholipids to prevent Alzheimer's-related blindness. This technology enhances DHA absorption and curcumin's anti-inflammatory benefits, potentially preserving vision in AD patients.
Overview
This innovative technology focuses on the nanoencapsulation of Omega-3 fatty acids (DHA) and curcumin using lysophospholipids. The solution aims to prevent Alzheimer's disease-related blindness by enhancing the bioavailability and efficacy of these compounds in the retina. While DHA is critical for visual function, traditional supplements like fish oil have failed to improve retinal DHA levels. By utilizing lysophospholipids, this approach significantly enriches retinal DHA. Coupled with curcumin's anti-inflammatory and antioxidant properties, the nanoencapsulation offers a promising strategy for preserving vision in Alzheimer's patients.
Technical specifications
- Nanoencapsulation technology: Utilizes biodegradable lysophospholipids to encapsulate DHA and curcumin
- Enhanced absorption: Nanoemulsions ensure efficient absorption and tissue enrichment of curcumin
- Dual action: Combines DHA's role in visual function with curcumin's anti-inflammatory benefits
- Preclinical validation: Includes solubility measurements, absorption tests using in vitro intestinal everted sacs, and in vivo experiments to assess brain bioavailability
Technology readiness level
This technology is currently at Technology Readiness Level 2 (TRL 2), indicating that the concept has been formulated and the potential benefits of the nanoencapsulation approach have been identified. Preclinical studies are underway to collect data necessary for future clinical trials aimed at evaluating this novel therapeutic approach.
About University of Illinois Chicago
UIC researchers are advancing discoveries across the life sciences, engineering, computer science, energy, manufacturing, public health, biomedical and other fields. Our scientists are supported by funding from the National Institutes of Health, National Science Foundation, U.S. Department of Energy, and other federal agencies.
Through UI Health, UIC offers a major academic health system with deep expertise in translational research, clinical trials, health information sciences and community-engaged healthcare. Beyond campus, UIC collaborates extensively with industry, other universities, national laboratories, government agencies, healthcare systems, and nonprofit organizations to translate research into real-world impact. From cutting-edge core facilities and specialized research infrastructure to world-class faculty and interdisciplinary research centers, UIC provides partners with access to a uniquely urban innovation ecosystem designed to accelerate discovery, commercialization and societal benefit.
Inquire about this partnering listing
Industry applications
delivered to your inbox.